Recro Pharma Inc (REPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REPH | KPTI | FGEN | ||
| Company | Recro Pharma Inc | Karyopharm Therapeut | Fibrogen Inc CS | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.07 | 1.1000 | 1.1900 | ||
| High | 2.14 | 1.1300 | 1.2300 | ||
| Low | 2.00 | 1.0450 | 1.1300 | ||
| Last | 2.09 | 1.0850 | 1.1200 | ||
| Change | -0.01 | +0.0050 | -0.0500 | ||
| % Change | -0.48% | +0.46% | -4.27% | ||
| Volume | 141,800 | 694,532 | 661,344 | ||
| 20-Day Average Volume | 122,300 | 1,126,651 | 1,175,101 | ||
| Previous Close | 2.10 | 1.0800 | 1.1700 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.84 | 1.1858 | 1.2412 | ||
| 20-Day Raw Stochastic | 85.07% | 22.65% | 30.09% | ||
| 20-Day Relative Strength | 65.13% | 45.46% | 39.23% | ||
| Weighted Alpha | -25.90 | -58.19 | -79.76 | ||
| Today's Opinion | 40% Buy | 8% Sell | 24% Sell | ||
| Previous Opinion | 40% Buy | 8% Sell | 24% Sell | ||
| Last Month's Opinion | 56% Sell | 48% Buy | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.18% since 03/14/22 | +4.77% since 04/25/24 | +11.76% since 04/25/24 | ||
| Low | 1.94 on 03/15/22 | 1.0200 on 04/30/24 | 0.9754 on 04/26/24 | ||
| High | 2.19 on 03/18/22 | 1.1700 on 04/29/24 | 1.2300 on 05/02/24 | ||
| 1-Month | |||||
| %Chg | +30.62% since 02/18/22 | -20.39% since 04/02/24 | -47.22% since 04/02/24 | ||
| Low | 1.52 on 02/24/22 | 1.0200 on 04/30/24 | 0.9011 on 04/25/24 | ||
| High | 2.19 on 03/18/22 | 1.4400 on 04/04/24 | 2.1500 on 04/03/24 | ||
| 3-Month | |||||
| %Chg | +35.71% since 12/21/21 | +6.79% since 02/02/24 | -38.71% since 02/02/24 | ||
| Low | 1.42 on 01/31/22 | 1.0200 on 04/30/24 | 0.9011 on 04/25/24 | ||
| High | 2.19 on 03/18/22 | 1.9500 on 02/06/24 | 2.9300 on 02/12/24 | ||
| 6-Month | |||||
| %Chg | +1.95% since 09/21/21 | +45.88% since 11/02/23 | +101.06% since 11/02/23 | ||
| Low | 1.38 on 12/06/21 | 0.6174 on 12/11/23 | 0.3333 on 11/10/23 | ||
| High | 2.20 on 09/23/21 | 1.9500 on 02/06/24 | 2.9300 on 02/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 117,926 | 125,783 | 116,385 | ||
| Shares Outstanding, K | 56,424 | 116,466 | 99,474 | ||
| Annual Sales | 75,360,000 | 146,030,000 | 147,750,000 | ||
| Annual Net Income | -11,370,000 | -143,100,000 | -284,230,000 | ||
| Last Quarter Sales | 22,300,000 | 33,750,000 | 27,140,000 | ||
| Last Quarter Net Income | -2,360,000 | -41,840,000 | -56,230,000 | ||
| 60-Month Beta | 1.08 | 0.16 | 0.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.36 on 02/29/24 | -0.57 on 02/26/24 | ||
| Latest Earnings Date | 05/05/22 | 05/02/24 | 05/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||